Allied Research International (ARI), Canada's leading contract research organization (CRO), announced today that it has acquired key assets of South Florida Bioavailability Clinic International's (SFBC) Miami, Florida operations.
TORONTO – August 16, 2006 – Allied Research International (ARI), Canada's leading contract research organization (CRO), announced today that it has acquired key assets of South Florida Bioavailability Clinic International's (SFBC) Miami, Florida operations. The acquired assets include a fully-functional clinical laboratory and equipment, and a 46-station cardiac monitoring suite.
"These assets will be re-located to ARI's new state-of-the-art, 150-bed Phase 1 clinic in Miami that opened this spring. ARI will also employ selected leading staff from SFBC's Miami operations," said Dr. Piyush Patel MD, CEO and Founder of ARI.
ARI now has significantly expanded capacity to perform complex Phase 1 and special population studies in the Miami area, There is a large need for these types of studies and for which few other CROs specialize.
The expanded facilities in Miami add to ARI's 80-bed Phase 1 unit in Toronto, Canada, bringing its total capacity to over 230 Phase I beds.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.